Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR)

CUSIP: 929033207

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+20,842,485
Put/Call ratio
35%
SEC-reported price per share
$13.08
Number of holders
54
Value change
+$261,622,068
Number of buys
46
Open additional details 1 more signal available
Number of sells
12
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
51,352,293

Security key

929033207

Report period

Q4 2025

Institutions

54

Top holders

10

Ownership snapshot

Top reported holders of VOR - Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Reprogrammed Interchange LLC
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 3/4/5 13F Lead comparable stake: 18% 13D/G row: Reprogrammed Interchange LLC Showing 1-6 of 15 holder rows.

Quick read

Reprogrammed Interchange LLC leads the comparable SEC ownership view at 18%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Reprogrammed Interchange LLC's linked filing trail.
Comparable ownership Top 5
Reprogrammed Interchange LLC 18%
RA CAPITAL MANAGEMENT, L.P. 14%
ForGrowth III PA B.V. 10%
FMR LLC 6.5%
Frazier Life Sciences Public Fund... 5.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Reprogrammed Interchange LLC
13D/G 3/4/5
10%+ Owner
18%
$48,045,191
1,204,442 shares
$0 15 Oct 2025
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G
Company
14%
from 13D/G
$96,577,705
1,982,301 shares
30 Sep 2025
ForGrowth III PA B.V.
13D/G
10%
$81,492,203
10,237,714 shares
+$25,772,203 18 Dec 2025
FMR LLC
13D/G 13F
Company
6.5%
$37,185,222
2,526,170 shares
+$25,579,283 31 Dec 2025
Frazier Life Sciences Public Fund, L.P.
13D/G
5.8%
$17,973,688
2,258,001 shares
$0 18 Dec 2025
Paradigm Biocapital Advisors LP
13D/G
4.5%
$23,730,000
1,750,000 shares
$0 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
54
Shares
25,547,116
Rows available
54
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
35
Q4 2025 holders
54
Holder diff
19
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .